Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 160.8 SEK -1.65% Market Closed
Market Cap: 12.8B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Cost of Revenue Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Cost of Revenue
-kr794m
CAGR 3-Years
-19%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
AddLife AB
STO:ALIF B
Cost of Revenue
-kr6B
CAGR 3-Years
-21%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cost of Revenue
-kr1.1B
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Cost of Revenue
-kr45.2m
CAGR 3-Years
-43%
CAGR 5-Years
-64%
CAGR 10-Years
-12%
MedCap AB (publ)
STO:MCAP
Cost of Revenue
-kr954.9m
CAGR 3-Years
-32%
CAGR 5-Years
-24%
CAGR 10-Years
-4%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cost of Revenue
-kr16.5m
CAGR 3-Years
18%
CAGR 5-Years
-6%
CAGR 10-Years
N/A

See Also

What is Biotage AB's Cost of Revenue?
Cost of Revenue
-794m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Cost of Revenue amounts to -794m SEK.

What is Biotage AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-14%

Over the last year, the Cost of Revenue growth was -28%. The average annual Cost of Revenue growth rates for Biotage AB have been -19% over the past three years , -15% over the past five years , and -14% over the past ten years .

Back to Top